Publication:

Uncovering a novel mechanism whereby NK cells interfere with glioblastoma virotherapy

Thumbnail Image

Open/View Files

3654589.pdf (290.76 KB)

Date

2013

Authors

Published Version

10.4161/onci.23658

Journal Title

Journal ISSN

Volume Title

Publisher

Landes Bioscience
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Alvarez-Breckenridge, Christopher A., Jianhua Yu, Michael A. Caligiuri, and E. Antonio Chiocca. 2013. “Uncovering a novel mechanism whereby NK cells interfere with glioblastoma virotherapy.” Oncoimmunology 2 (4): e23658. doi:10.4161/onci.23658. http://dx.doi.org/10.4161/onci.23658.

Abstract

Despite initial promising results, the success of clinical trials testing oncolytic viruses in glioblastoma patients has been limited. Innate immunity appears to be one among several barriers against successful viral oncolysis. Recent findings suggest a mechanism by which natural killer cells limit the efficacy of oncolytic viruses via natural cytotoxicity receptors.

Description

Other Available Sources

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654589/pdf/

Research Data

Keywords

brain tumor, cancer, glioblastoma, innate immunity, oncolytic virus

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

URI

http://nrs.harvard.edu/urn-3:HUL.InstRepos:11708645

Collections

HMS Scholarly Articles

Endorsement

Review

Supplemented By

Related Stories